Response to Immunization with A and B Human Glycoproteins for the Procurement of Blood Grouping Reagents
- 1 September 1984
- journal article
- research article
- Published by Wiley in Vox Sanguinis
- Vol. 47 (3) , 224-235
- https://doi.org/10.1111/j.1423-0410.1984.tb01590.x
Abstract
Subjects (37) were immunized with A or B human blood group substances. All subjects showed at least a 3-fold increase in potency of their ABO antibodies. Use of the resulting plasma has considerably improved the quality of ABO grouping reagents. The IgG component of these antibodies increased in all subjects and an IgA component was seen in the majority of post-immunization samples. All group O subjects developed cross-reacting anti-A,B antibodies.This publication has 12 references indexed in Scilit:
- Les anticorps monoclonaux dirigés contre les antigènes de groupes sanguinsRevue Française de Transfusion et Immuno-hématologie, 1982
- Monoclonal Anti‐B as a New Blood‐Typing ReagentVox Sanguinis, 1981
- Monoclonal Anti‐A from a Hybrid‐Myeloma: Evaluation as a Blood Grouping ReagentVox Sanguinis, 1980
- Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysisCell, 1978
- Serological Characteristics of Anti-A Related to Type of Antibody Protein (7S γ or 19S γ)Vox Sanguinis, 1963
- Antibody elution from red blood cellsJournal of Clinical Pathology, 1963
- LINKED ANTI-A AND ANTI-B ANTIBODIES FROM GROUP-O SERA1952
- “AVIDITY” OF ANTI-A AGGLUTINATING SERAQuarterly Journal of Experimental Physiology and Cognate Medical Sciences, 1947
- SEROLOGICAL STUDIES ON THE BLOOD OF THE PRIMATESThe Journal of Experimental Medicine, 1925